Powers drafted the attached template COVID-19 Policies and Procedures that incorporate HRSA/OPA’s relaxed guidance to help 340B covered entities address the coronavirus pandemic. We hope
On April 2, the Food and Drug Administration (FDA) announced that, effective immediately, it is modifying its current policy to shorten the abstinence period, from
